Skip to content
Condition

Cerebral Amyloid Angiopathy

Cerebral amyloid angiopathy (CAA) is a condition where a protein called amyloid builds up in the walls of small blood vessels in the brain. This buildup weakens the vessels, making them prone to bleeding, which can cause strokes, seizures, or confusion. CAA is more common in older adults and can contribute to memory problems over time.

What is Cerebral Amyloid Angiopathy?

Cerebral amyloid angiopathy (CAA) is a brain condition where abnormal protein deposits, called amyloid-beta, collect in the walls of small to medium-sized blood vessels. This buildup makes the vessels weak and fragile, increasing the risk of bleeding into the brain, which can lead to strokes, seizures, or other neurological issues. It primarily affects the outer layers of the brain.

CAA happens when amyloid-beta protein, which is naturally found in the body, starts to accumulate in the brain's blood vessel walls. Think of it like rust building up inside old pipes, making them brittle and more likely to burst. These weakened vessels can then leak blood, causing small or large bleeds (hemorrhages) in the brain. These bleeds can damage brain tissue and disrupt normal brain function. In some cases, CAA can also cause inflammation in the brain. While many people with CAA have no symptoms, the condition can lead to serious problems like sudden strokes or a gradual decline in thinking abilities. CAA is different from Alzheimer's disease, even though both involve amyloid-beta protein. In Alzheimer's, amyloid builds up as plaques between brain cells. In CAA, it specifically targets the blood vessel walls. However, many people with Alzheimer's also have CAA.

Symptoms

Symptoms of cerebral amyloid angiopathy (CAA) often appear suddenly and depend on where a brain bleed occurs, or they can be temporary. Common symptoms include severe headaches, seizures, confusion, weakness or numbness on one side of the body, and changes in vision. Some people may also experience temporary episodes of neurological symptoms.

Many people with CAA do not have any noticeable symptoms, especially if the bleeds are very small (microbleeds). However, if a larger bleed occurs, symptoms can come on very quickly. These might include a sudden, severe headache, which can be a sign of bleeding in the brain. Other symptoms can include seizures, which are sudden, uncontrolled electrical disturbances in the brain. You might also experience confusion, difficulty speaking, or problems understanding others. Weakness or numbness on one side of your body, or changes in your vision, are also possible, similar to symptoms of a stroke. Some individuals with CAA may have "amyloid spells" (transient focal neurological episodes). These are temporary episodes where you might feel numbness, tingling, weakness, or have visual disturbances that come and go. Over time, CAA can also contribute to problems with memory and thinking (cognitive decline) and may increase the risk of developing dementia.

Causes & risk factors

The exact cause of cerebral amyloid angiopathy (CAA) is not fully understood, but it involves the buildup of amyloid-beta protein in brain blood vessels. The strongest risk factor for CAA is increasing age, typically affecting adults over 60. While most cases are sporadic, a small number are linked to specific genetic factors.

The main underlying cause of CAA is the abnormal accumulation of amyloid-beta protein in the walls of the brain's small arteries. This protein is normally present in the body, but in CAA, it folds incorrectly and deposits in a way that weakens the blood vessels. Scientists are still researching why this happens in some people and not others. The most significant risk factor for developing CAA is age. It is much more common in older adults, especially those over 60 or 70 years old. The risk increases as people get older. While CAA is often found in people with Alzheimer's disease, it is important to remember that CAA is a separate condition. Not everyone with CAA will develop Alzheimer's, and vice versa, though the two conditions often coexist. Most cases of CAA are sporadic, meaning they occur without a clear inherited cause. However, very rarely, CAA can be linked to specific genetic mutations that run in families. If you have a family history of CAA, your doctor might discuss genetic counseling with you.

How it's diagnosed

Cerebral amyloid angiopathy (CAA) is primarily diagnosed using brain imaging techniques, especially magnetic resonance imaging (MRI). An MRI can detect characteristic signs like small bleeds (microhemorrhages), larger hemorrhages, and other changes in the brain's white matter. A computed tomography (CT) scan may be used for acute bleeds.

When a doctor suspects CAA, they will typically order a brain MRI. This imaging test is very effective at showing the specific patterns of amyloid buildup and the damage it causes. An MRI can reveal tiny spots of old blood (microhemorrhages) and larger areas of bleeding in the brain. It can also show changes in the brain's white matter and a condition called superficial siderosis, which is iron deposits from old bleeds on the brain's surface. In emergency situations, such as a sudden severe headache or stroke-like symptoms, a computed tomography (CT) scan of the brain might be performed first. A CT scan can quickly identify fresh bleeding in the brain, helping doctors make immediate treatment decisions. A definitive diagnosis of CAA can only be made by examining brain tissue under a microscope, usually obtained through a brain biopsy. However, this procedure is rarely done on living individuals due to the risks involved. Most diagnoses are made based on the characteristic findings from MRI scans and a person's symptoms.

Treatment options

There is currently no specific treatment to remove the amyloid protein deposits that cause cerebral amyloid angiopathy (CAA). Treatment focuses on managing symptoms, preventing complications like further bleeding, and controlling risk factors. This often involves careful blood pressure management and avoiding certain medications that increase bleeding risk.

Since there is no cure for the amyloid buildup itself, treatment for CAA is mainly supportive. This means doctors focus on managing any symptoms you experience and trying to prevent future problems. For example, if you have seizures, your doctor will prescribe anti-seizure medications to control them. Managing high blood pressure (hypertension) is very important for people with CAA. Keeping your blood pressure well-controlled can help reduce the risk of future brain bleeds. Your doctor will carefully review all your medications, especially blood thinners (anticoagulants) or antiplatelet drugs, as these can increase the risk of bleeding in people with weakened blood vessels. In many cases, these medications may need to be stopped or adjusted. If a large brain bleed occurs and is life-threatening, surgery might be considered to remove the blood and relieve pressure on the brain. However, surgery is not always an option and carries its own risks. Your care team will work with you to create a personalized treatment plan based on your specific symptoms and overall health.

Recovery & outlook

The recovery and outlook for cerebral amyloid angiopathy (CAA) vary greatly among individuals, depending on the severity and location of any brain bleeds. CAA is generally a progressive condition, meaning it can worsen over time, and there is a risk of recurrent bleeds. Many people may experience long-term neurological effects or cognitive decline.

Recovery from a brain bleed caused by CAA can be a long process. Some people may recover fully, while others might experience lasting effects such as weakness, speech problems, or memory issues. The extent of recovery depends on how much brain damage occurred and how quickly medical attention was received. Because CAA is a progressive condition, there is a risk of having more brain bleeds in the future. Each bleed can potentially cause new or worsening symptoms. Regular follow-up with your doctor and adherence to your treatment plan, especially blood pressure control, are crucial to help manage the condition and potentially reduce the risk of further complications. Over time, CAA can contribute to cognitive decline, affecting memory, thinking, and problem-solving abilities. While some people may maintain good cognitive function, others may develop dementia. It's important to discuss any changes in your memory or thinking with your doctor so they can be monitored and managed appropriately.

When to see a doctor

You should seek immediate medical attention if you experience sudden, severe symptoms that could indicate a brain bleed or stroke. These include a sudden, excruciating headache, sudden weakness or numbness on one side of your body, difficulty speaking or understanding, vision changes, or new seizures. These are medical emergencies.

If you or someone you are with experiences any sudden and severe neurological symptoms, it is crucial to call emergency services (like 911 in the US) right away. Do not wait to see if the symptoms improve. Prompt medical care is essential for brain bleeds and strokes to minimize damage and improve outcomes. Specific emergency signs to watch for include: a headache that comes on suddenly and is the "worst headache of your life"; sudden weakness or numbness, especially on one side of your face, arm, or leg; sudden confusion or trouble speaking or understanding speech; sudden problems with vision in one or both eyes; sudden dizziness, loss of balance, or coordination; or a new onset of seizures. Even if symptoms are temporary, like those in an "amyloid spell," it is important to report them to your doctor promptly. While not always an emergency, these episodes can be a sign of underlying CAA and warrant medical evaluation to understand their cause and manage your condition effectively.

Frequently asked questions

Is cerebral amyloid angiopathy (CAA) the same as Alzheimer's disease?

No, CAA is not the same as Alzheimer's disease, although both conditions involve the buildup of amyloid-beta protein in the brain. In CAA, amyloid primarily affects the blood vessel walls, while in Alzheimer's, it forms plaques between brain cells. Many people with Alzheimer's also have CAA, but they are distinct conditions.

Can CAA be inherited?

Most cases of cerebral amyloid angiopathy (CAA) are sporadic, meaning they are not inherited. However, a very small number of CAA cases are linked to specific genetic mutations that run in families. If you have a family history of CAA, your doctor might recommend genetic counseling.

What is the main risk factor for developing CAA?

The strongest risk factor for developing cerebral amyloid angiopathy (CAA) is increasing age. It is much more common in older adults, typically affecting individuals over 60 or 70 years old. The risk of developing CAA generally increases with age.

Are there any lifestyle changes I can make to prevent CAA?

There are no proven lifestyle changes that can prevent the amyloid buildup in cerebral amyloid angiopathy (CAA). However, managing high blood pressure and maintaining overall brain health through a healthy lifestyle can help reduce the risk of complications like brain bleeds once CAA is present.

What are "amyloid spells"?

"Amyloid spells" (transient focal neurological episodes) are temporary symptoms that can occur in people with cerebral amyloid angiopathy (CAA). These episodes might involve sudden, brief numbness, tingling, weakness, or visual disturbances that come and go. They are caused by temporary disruptions in brain function due to CAA.

Is there a cure for cerebral amyloid angiopathy?

Currently, there is no specific cure for cerebral amyloid angiopathy (CAA) that can remove the amyloid protein deposits from the blood vessels. Treatment focuses on managing symptoms, preventing complications like brain bleeds, and controlling risk factors such as high blood pressure.

Sources

  • MedlinePlus — Cerebral Amyloid Angiopathy
  • Mayo Clinic — Cerebral Amyloid Angiopathy
  • Cochrane Library — Cerebral Amyloid Angiopathy
KA
Medical reviewer
Kathy Bacon

Reviewed this article for medical accuracy (2026-06-05).